Werewolf Therapeutics, Inc. (HOWL) vs Instil Bio, Inc. (TIL)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Instil Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 3:18 PM EDT
TIL
Instil Bio, Inc.
$6.94HealthcareDelayed quote: Oct 6, 2026, 3:14 PM EDT
Total return — HOWL vs TIL
growth of $100 · dividends reinvested · last 5yHOWL -94.2% (-43.5%/yr)TIL -98.2% (-55.1%/yr)HOWL compounded faster over this window
HOWL TIL
HOWL vs TIL: by the numbers
- •TIL is the larger company ($47M vs $45M market cap).
- •Both run net losses; TIL's is the smaller (0.00% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | HOWL | TIL |
|---|---|---|
| P/S ratio | 2.15 | N/A |
| P/B ratio | 2.77 | 0.44 |
Profitability
| Metric | HOWL | TIL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -164.82% | 0.00% |
| ROE | -212.45% | -28.20% |
| ROIC | -156.97% | -18.61% |
Growth (annualized)
| Metric | HOWL | TIL |
|---|---|---|
| Total return CAGR (5Y) | -44.27% | -54.60% |
Frequently asked
- How have HOWL and TIL total returns compared?
- Over the past 5 years, HOWL delivered -44.27% and TIL delivered -54.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.